What is the role of the European Medicines Agency (EMA) with respect to medical devices?

The European Medicines Agency (EMA) plays a pivotal role in the regulation of medicinal products within the EU, which includes overseeing the regulatory processes for both medicines and certain medical devices, particularly those that deliver medicinal products or have a medicinal purpose. While the EMA does not provide marketing authorization for all types of medical devices—this responsibility largely falls under the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), which are overseen by notified bodies—it does have a significant role in the regulatory landscape pertaining to medical devices, especially for combination products.

The EMA also engages in scientific evaluation and guidance regarding these products, ensuring that they meet the established safety and efficacy standards. This involvement is critical for maintaining the quality and safety of healthcare products available in the EU market.

The other options do not accurately characterize the EMA's responsibilities. For instance, while the EMA may be involved in clinical trials related to medicinal products, it does not conduct clinical trials for medical devices itself, nor does it set pricing standards for medical devices in the EU, as pricing is typically managed by national authorities or other entities. Thus, the choice that best aligns with the EMA's role is its oversight in the regulation of medicines and certain medical devices within the European Union.